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Abstract
In this editorial, we first summarize the 2016 International Conference on Intelligent Biology and Medicine (ICIBM
2016) that was held on December 8–10, 2016 in Houston, Texas, USA, and then briefly introduce the ten research
articles included in this supplement issue. ICIBM 2016 included four workshops or tutorials, four keynote lectures,
four conference invited talks, eight concurrent scientific sessions and a poster session for 53 accepted abstracts, covering
current topics in bioinformatics, systems biology, intelligent computing, and biomedical informatics. Through our call for
papers, a total of 77 original manuscripts were submitted to ICIBM 2016. After peer review, 11 articles were selected in
this special issue, covering topics such as single cell RNA-seq analysis method, genome sequence and variation analysis,
bioinformatics method for vaccine development, and cancer genomics.
Introduction
The 2016 International Conference on Intelligent Biology
and Medicine (ICIBM 2016) was held from December 8th
to 10th, 2016 in Houston, Texas, USA. This is the fifth
annual ICIBM conference. ICIBM conference series have
two main aims: 1) to foster interdisciplinary and multi-
disciplinary research in bioinformatics, systems biology,
intelligent computing, bioengineering, and data sci-
ences, and 2) to provide an educational program for
trainees and young investigators across a range of
scientific disciplines to learn the frontier research in
these areas and to build a network among both the
established and junior investigators.
After 4 years of successful conference programs [1–4],
ICIBM 2016 turned out to be the largest of all the ICIBM
series in all aspects: number of attendees, talks, abstracts,
posters, etc. It served as a platform for bringing together
more than 150 scientists or trainees across the world with
diverse backgrounds and training ranging from biology,
medicine, computer science, bioengineering, bioinformat-
ics, statistics, mathematics, and genomics, among others.
We received 77 original manuscripts and 53 abstracts.
These manuscripts and abstracts covered research topics
including next-generation sequencing (NGS), genomics
and other omics research, biological pathway and network
analysis, computational algorithms, methods and tools.
An emerging research area at ICIBM is data science espe-
cially in medical data. ICIBM 2016 brought a special
session on this specific topic. Thanks to the grant support
from the National Science Foundation, we were able to
provide 22 travel awards to trainees from diverse back-
grounds across both the USA and international institu-
tions. As before, we formed the Award Committee to
review and select the travel awards based on the quality of
the research (paper or abstract), the financial need, and di-
versity/minority of the attendees. In the following section,
we summarize the scientific program of the ICIBM 2016
and provide an editorial report of the 11 research articles
included in this BMC Genomics supplement issue.
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ICIBM 2016 scientific program
The ICIBM 2016 spanned 3 days and its scientific pro-
gram included 4 workshops/tutorials, 4 keynote lectures,
4 conference invited talks, 8 concurrent scientific sessions
and a poster session with 53 accepted abstracts. The
presentations covered emerging areas of bioinformatics,
systems biology, intelligent computing, data sciences, and
biomedical informatics. In the following sections, we
briefly review the keynote lectures, conference invited
talks, workshops/tutorials, scientific sessions and the pos-
ter session.
Keynote lectures
Four world-renowned scientists presented keynote lectures
on their innovative research and shared their perspectives.
These speakers were Dr. Trey Ideker from the University
of California at San Diego, Dr. John Weinstein from The
University of Texas MD Anderson Cancer Center, Dr.
Edward Marcotte from The University of Texas at Austin,
and Dr. Yi Xing from The University of California at Los
Angeles.
“Siri of the Cell – Intelligent agents for systems medi-
cine constructed using systems data” by Dr. Trey Ideker.
In the keynote lecture, Dr. Ideker introduced how we
can feed omics data into multiscale models of the cell
using similar intelligent agents, like Siri for cellular
phone, to predict a range of cellular phenotypes and an-
swer various biological questions. Dr. Ideker is a Professor
of Genetics in the Department of Medicine at the Univer-
sity of California at San Diego (UCSD). He serves as the
Director of the San Diego Center for Systems Biology. He
is also the adjunct professor of Computer Science and
Bioengineering and member of the Moores UCSD Cancer
Center. Dr. Ideker has founded influential bioinformatic
tools including Cytoscape, a popular network analysis
platform which has been cited >12,000 times. He serves
on the Editorial Boards for Cell, Cell Reports, Nature
Scientific Data, EMBO Molecular Systems Biology, and
PLoS Computational Biology and is a Fellow of AAAS
and AIMBE.
“Evolution and the proteome: Insights into protein func-
tion from deeply conserved gene modules” by Dr. Edward
Marcotte. Dr. Marcotte described his approaches to test
the predictive information of the deeply homologous
genes and pathways. He discussed his search for new
models of human disease among phenotypes of distant
organisms, his attempts to systematically humanize yeast
cells, and his program to apply high-throughput protein
mass spectrometry in order to measure conserved phys-
ical interactions among the thousands of proteins shared
across the eukaryotic tree of life. Dr. Marcotte is a Profes-
sor in the Department of Molecular Biosciences at the
University of Texas, where he holds the Mr. and Mrs.
Corbin J. Robertson, Sr. Regents Chair in Molecular
Biology and co-directs the UT Center for Systems and
Synthetic Biology. His research falls in the general areas of
proteomics, bioinformatics, and systems and synthetic
biology, with current work focused on the interactions,
dynamics, and evolution of proteins across the tree of life.
He has received a National Institutes of Health Director’s
Pioneer Award, and is a Fellow of the Royal Society of
Chemistry, the American Academy of Microbiology, and
the American Association for the Advancement of
Science.
“Molecular profiling of cancers: The Cancer Genome
Atlas project and beyond” by Dr. John Weinstein. In the
lecture, Dr. Weinstein shared the recent exciting find-
ings as well as the challenges of The Cancer Genome
Atlas (TCGA) project. TCGA currently constitutes 33
tumor types and provides molecular, pathological, and
clinical data that can be mined for generations. Specific-
ally, he pointed out that the sophisticated bioinformatics
and computational tools developed around this data will
be very beneficial in the long run. Dr. Weinstein is the
Professor and Chair of the Department of Bioinformatics
and Computational Biology at the University of Texas
MD Anderson Cancer Center. He has over more than
300 publications, including 15 as first author in Science
or Nature, 11 that have been cited in the literature more
than 600 times each, and more than 40 in journals with
impact factors higher than 30. He is cited as “a pioneer
of the post-genomic era in biomedical science.” His
research group applies a mix of genomic, proteomic,
metabolomics, systems biological, and bioinformatic
tools to the search of new biomarkers, prevention strat-
egies, and therapies for cancer. He is the leader of many
large-scale cancer research projects such as TCGA,
CCLE, and GDSC.
“Elucidate transcriptome isoform complexity using
massive RNA-seq data” by Dr. Yi Xing. Dr. Xing presented
the recent advances in high-throughput RNA sequencing
(RNA-seq) technology, which have provided a powerful
tool for transcriptome-wide measurements of mRNA
isoform complexity at an unprecedented resolution.
He discussed his recent efforts in developing compu-
tational and statistical methods for elucidating tran-
scriptome isoform complexity using massive RNA-seq
datasets. Dr. Xing is a Professor in the Department of
Microbiology, Immunology and Molecular Genetics at
University of California at Los Angeles (UCLA) and
the director of UCLA’s Bioinformatics and Inter-
departmental PhD Program. His research focuses on
combining genomic, bioinformatics, molecular, and sys-
tems approaches to elucidate the variation and dynamics
of RNA regulatory networks in development and disease.
Dr. Xing has received prestigious young investigator re-
search awards from the Sloan Foundation and the March
of Dimes Foundation.
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Conference invited talks
ICIBM 2016 featured four conference invited talks cov-
ering frontier and emerging research topics such as
novel regulatory roles of 3′ untranslated region (UTR)
shortening in tumorigenesis, tumor-stroma crosstalk in
tumor microenvironment for drug combinations, tumor
phylogeny inference using single-cell DNA sequencing
data, and functional proteomics in precision cancer
medicine, etc. Each speaker has developed cutting-edge
technologies or methods in bioinformatics and genomics
fields.
“3′-UTR shortening represses tumor suppressors in trans
by disrupting ceRNA crosstalk” by Dr. Wei Li, professor at
Baylor College of Medicine. Dr. Li presented that shortened
3′-UTRs in breast cancers are strongly associated with re-
pression of tumor suppressors enriched in competing
endogenous RNAs (ceRNAs). He also introduced his
model-based analysis of the trans effect of 3′-UTR
shortening (MAT3UTR), which predicts many trans-
targets of 3′-UTR shortening, including PTEN, a crucial
tumor suppressor involved in ceRNA crosstalk. Through
big data analysis followed by functional validation, they
found that the major role of 3′-UTR shortening in
tumorigenesis is to repress tumor suppressors in trans,
rather than induce proto-oncogenes in cis.
“Modelling tumor-stroma crosstalk in tumor microenvir-
onment for drug combinations and biomarker discovery in
cancer” by Dr. Stephen Wong, Chairman and Professor of
Department of Systems Medicine and Bioengineering at
Houston Methodist Hospital and Cornell University. In his
talk, Dr. Wong reviewed a body of the computational work
in his lab that model tumor microenvironment in cancer
and the discovery of drug combination and biomarkers in
cancer. His solid data demonstrated that bioinformatics ap-
proaches are important for drug and biomarker discovery
in cancer.
“Tumor phylogeny inference from single-cell DNA se-
quencing data” by Dr. Ken Chen, Associate Professor at
the Department of Bioinformatics and Computational Biol-
ogy and the Director of Bioinformatics of Khalifa Institute
of Personalized Cancer Therapy, the University of Texas
MD Anderson Cancer Center. Dr. Chen talked about how
he overcame some of the computational challenges by
developing a suite of new algorithms for single-cell DNA
sequencing technology in cancer research, including
Monovar, SiFit, and novoBreak.
“Functional proteomics as a major approach for precision
cancer medicine” by Dr. Han Liang, Associate Professor at
the Department of Bioinformatics and Computational Biol-
ogy, the University of Texas MD Anderson Cancer Center.
Dr. Liang presented his work for evaluating biomarkers and
elucidating the mechanisms underlying the sensitivity and
resistance to cancer therapy using reverse-phase protein ar-
rays (RPPAs) data. His team developed protein-based
prognostic models for stratifying patients into different risk
groups by integrating RPPA data and TCGA data from
independent patient cohorts. His work demonstrates the
utility of RPPA as a powerful approach in prognostic and
therapeutic strategies for precision cancer medicine.
Workshops
ICIBM 2016 included four workshops/tutorials, which
covered important techniques such as pathway and
network analysis, statistical clustering analysis of multi-
omics data, high throughput data analysis, and ENCODE
data analysis and visualization. These workshops/tuto-
rials were well attended and appreciated by the confer-
ence participants. They discussed the various strategies
and at times provided the attendees with hands-on exer-
cise using open source tools.
“Tutorial: Introduction to pathway and network ana-
lysis.” This tutorial was organized by Dr. Amin Momin
from MD Anderson Cancer Center. Dr. Momin intro-
duced the attendees about pathway and network analysis,
which have mainly emerged as two robust technologies
that provide biological annotation based on empirical and
predicted findings. The participants also had an opportun-
ity to do some hands-on exercise using open source tools
to practice these techniques.
“Tutorial: Statistical methods for integrative clustering
analysis of multi-omics data.” This tutorial was orga-
nized by Dr. Qianxing Mo from Baylor College of Medi-
cine. Dr. Mo introduced the iClusterPlus method and a
newly developed statistical method for integrative clus-
tering analysis of the multi-omics data. He also intro-
duced the theoretical background of the integrative
clustering methods and illustrated the methods using
TCGA multi-omics cancer data. Through the tutorial,
attendees obtained hands-on experience with integrative
clustering analysis of multi-omics data.
“Workshop: High throughput data analysis, DNA, RNA,
microbiome sequencing and genotyping.” Organizer Dr.
Yan Guo from Vanderbilt University Medical Center
introduced the background, quality control, processing
and interpretation for each of the four types of high
throughput genomic data. This workshop helped attendees
understand the technology background and the standard
analysis pipeline and interpretation of the results for each
type of genomic data.
“Workshop: Interactive workshop on ENCODE data ana-
lysis and visualization.” Organizer Dr. Yue Feng from
Pennsylvania State University College of Medicine illus-
trated and provided hands-on tutorial on using ENCODE
portal website, including how to browse, search and
download ENCODE data. He introduced users to EN-
CODE analysis pipeline and REST APIs, explained an-
notations (such as enhancers and promoters) and its
query website, and demonstrated how to visualize the
The Author(s) BMC Genomics 2017, 18(Suppl 6):703 Page 3 of 142
3D genome organization data (Hi-C and ChIA-PET)
generated by ENCODE consortium.
Scientific sessions
ICIBM 2016 had eight concurrent scientific sessions,
which were incredibly valuable to research, education
and innovation. Speakers were chosen from those top
ranked manuscripts after peer review and they were
from various fields of bioinformatics, genomics, systems
biology, intelligent computing, and biomedical informat-
ics. The eight session are:
Session I: Genome Structure Analysis and Visualization
Session II: NGS Analysis and Tools I
Session III: Computational Drug Discovery
Session IV: Medical Informatics and Big Data
Session V: NGS Analysis and Tools II
Session VI: Cancer Genomics
Session VII: Systems Biology
Session VIII: Big Data and Machine Learning
In addition, our poster session had a total of 53 abstracts
for poster presentation. The topics included emerging
research areas such as bioinformatics, genomics and
genetics, next generation sequencing data analysis, big
data science including storage, analysis, modelling and
visualization, personalized medicine, drug discovery, drug
designing, drug repurposing, proteomics, image analysis
and processing, modelling and simulation of biological
processes, pathways and networks, mathematical and
quantitative models of cellular and multi-cellular systems,
multi-dimensional omics data integration, metabolomics,
application of systems biology approaches to biomedical
sciences, machine learning, data mining, pattern recog-
nition, natural language processing, literature mining,
semantic oncology, neural computing, kernel methods,
evolutionary computing, ensemble methods, manifold
learning theory, artificial life and artificial immune
systems.
The details of these sessions were included on the con-
ference website as well as in the program book, which was
handed out to the attendees during the conference. Here,
we provide an editorial report of the supplements to BMC
Genomics that include 11 research papers selected from
77 manuscripts submitted to ICIBM 2016. Each manu-
script was reviewed by at least two reviewers (most by
three reviewers) and was substantially revised by taking
care of the reviewers’ critiques before further review and
acceptance. Other selected papers were accepted in other
BMC journals: BMC Systems Biology, BMC Bioinformat-
ics, BMC Medical Informatics and Decision Making, and
BMC Medical Genomics.
In the first paper, Yang et al. [5] introduced a novel
algorithm, namely SAIC (Single cell Analysis via Iterative
Clustering), that identifies the optimal set of signature
genes from single cell RNA-seq data and separates single
cells into distinct clusters. Their method utilizes an it-
erative clustering approach to perform an exhaustive
search for the best parameters within the search space.
The outcome is to identify signature gene set that gives
the best separation of the cell clusters. The authors ap-
plied SAIC to one simulation dataset and two published
single cell RNA-seq datasets and found it performed
better than PCA method based on DB index score.
Chi-square statistics based on word pattern frequencies
have long been proposed for molecular sequence compari-
son, but the optimal size of word patterns is not well stud-
ied. In comparison of two Markovian sequences, Bai et al.
[6] showed theoretically and by applications to simulated
and real data that the optimal word size equals the max-
imum order of the two sequences plus one. This critical
information is applicable to the comparison of both long
and next generation sequencing (NGS) short reads data.
This study provides guidance on the choice of word size
in alignment sequence comparison.
Hampton et al. [7] presented a breakpoint calling
tool, SVachra (Structural Variation Assessment of
CHRomosomal Aberrations), that identifies large in-
sertions or deletions, inversions, inter- and intra-
chromosomal translocations utilizing both inward and
outward facing read types generated by mate pair sequen-
cing. They demonstrated that SVachra exhibited the high-
est validation rate and reported the widest distribution of
SV types and size ranges when compared to other SV
callers.
Detecting the difference of single nucleotide variant
(SNV) called from DNA and RNA samples of the same
subject has been an interest of researchers. Through
careful quality control and analyses of SNVs inferred
from ten subjects with five distinct types of high through-
put sequencing data, Guo et al. [8] found high consistency
between DNA-DNA pairs and lower consistency in DNA-
RNA or RNA-RNA pairs. Majority of the DNA-RNA
difference were due to technical errors. Their findings
suggested that SNV detection using RNA-seq data is sub-
ject to high false positive rates.
Position weight matrix (PWM) and sequence logo are
the most widely used representations of transcription
factor binding site in biological sequences. Although
there are a few tools to generate sequence logos from
PWM, there is no tool does the reverse. In Gao et al. [9],
the authors proposed logo2PWM for reconstructing
PWMs from sequence logo images. Evaluation results on
over one thousand logos from different sources showed
that the correlation between the reconstructed PWMs
and the original PWMs were constantly high. logo2PWM
may benefit the study of transcription by filling the gap
between sequence logo and PWM.
Sher et al. [10] presented a new machine learning sys-
tem which combines deep neural networks, analytical
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learning, and text mining techniques to predict epitopes
using continuous primary protein sequence as input.
They combined these concepts together to produce a
pipeline called DRREP (Deep Ridge Regressed Epitope
Predictor). DRREP was benchmarked against other state
of the art epitope predictors, and achieved impressive
improvements over other methods.
Apaydin et al. [11] study the validity and robustness of
existing bi-level methods for strain optimization under
uncertainty and non-cooperative environment. Specific-
ally, the authors proposed new pessimistic optimization
formulations: P-ROOM and P-OptKnock, aiming to
derive robust mutants with the desired overproduction
under two different existing mutant cell survival models,
ROOM and OptKnock. Their pessimistic strain optimization
methods could produce more robust solutions regardless of
the inner-level mutant survival models, which are de-
sired as the models for cell survival are often approxi-
mate to real-world systems.
The incidence of kidney renal clear cell carcinoma
(KIRC) is expected to continue to increase in the US.
There is an urgent need to find effective diagnostic bio-
markers for KIRC that could help earlier detection and
customized treatment strategies. Using the data from
TCGA, Han et al. [12] found KIRC had many more pro-
tein prognostic biomarkers of survival time than other
cancer types. They identified 52 genes as well as 4
tumor-stage-specific genes whose mRNA and protein
expression were prognostic biomarkers of KIRC survival.
The study indicated that these biomarkers might have
clinical values for KIRC.
In another paper, Kuznetsov et al. [13] studied micro-
RNA signatures in 582 high-grade serous ovarian carcin-
omas (HG-SOC). They revealed two robust and unbiased
microRNA-based prognostic classifiers. They predicted
specific target genes involved in nine cancer-related and
two oocyte maturation pathways. Each gene in these path-
ways is regulated by more than one microRNA of the dis-
tinct microRNA-based prognostic classifiers. In total, the
authors identified three HG-SOC subtypes and suggested
possible microRNA-controlled common pathophysio-
logical mechanisms.
In the next paper, the authors [14] developed a system-
atic workflow to screen for key modulators on a genome-
wide scale based on gene expression profiles in cancer.
They applied the method to a dataset of 286 breast tu-
mors. They identified nearly a thousand key modulators,
and verified the results in three independent cohorts.
These modulators were involved in immune response and
hormone signaling. The study provided candidates for
further biological investigation in breast cancer.
In the last paper, Xu et al. [15] investigated the circular
RNA (circRNAs) expression profiles and features in ten
human tissues. Even though 33 circRNAs were found to
be expressed ubiquitously in all adult tissues, hundreds
of circRNAs have tissue specific expressions. Non-tissue
specific circRNAs were further analyzed through a
circRNA-miRNA-mRNA regulatory network. Further-
more, higher expression level of circRNAs in mammary
gland than other tissues might be attributed to the rich
innervation. Overall, this comprehensive study proposed
that circRNAs play their roles in a tissue-specific and
development-specific manner.
Conference organization
2016 international conference on intelligent biology and
medicine (ICIBM 2016)
(December 8–10, 2016, Houston, TX, USA)
We would like to express our sincere gratitude to the
members of the Steering, Program, Publication, Work-
shop/Tutorial, Publicity, Award, Trainee and Local
Organization Committees, as well as to all the reviewers
and volunteers, who spent their valuable time and effort
on making ICIBM 2016 a success. The conference accom-
plishments are the results of support and hard work of all
these people.
Hosts and sponsors
The University of Texas Health Science Center at
Houston (UTHealth), National Science Foundation,
The University of Texas at San Antonio, Rice University,
Baylor College of Medicine, Vanderbilt University,
UTHealth Center for Precision Health, Rice University
BioScience Research Collaborative.
General chairs
Zhongming Zhao (The University of Texas Health Science
Center at Houston) and Jiajie Zhang (The University of
Texas Health Science Center at Houston).
Steering committee
Wenjin J. Zheng (The University of Texas Health Science
Center at Houston), Yidong Chen (The University of
Texas Health Science Center at San Antonio), Tony Hu
(Drexel University), Han Liang (MD Anderson Cancer
Center), Steve Wong (Methodist Hospital/Cornell Univer-
sity), Michael Zhang (The University of Texas at Dallas).
Program committee
Chair: Zhandong Liu (Baylor College of Medicine), Co-
Chair: Genevera Allen (Rice University). Members: Kristen
Anton (Dartmouth College), Yongsheng Bai (Indiana State
University), William S. Bush (Case Western Reserve Uni-
versity), Jake Chen (University of Alabama at Birmingham),
Xue-Wen Chen (Wayne State University), Yidong Chen
(The University of Texas Health Science Center), Lee
Cooper (Emory University), Juan Cui (University of
Nebraska, Lincoln), Qinghua Cui (Peking University,
The Author(s) BMC Genomics 2017, 18(Suppl 6):703 Page 5 of 142
China), Youping Deng (Rush University Medical Center),
Joshua Denny (Vanderbilt University), Jeremy Edwards
(University of New Mexico Health Sciences Center),
Weixing Feng (Harbin Engineering University, China), M
Jennifer Fettweis (Virginia Commonwealth University),
Marcelo Fiszman (National Library of Medicine, National
Institutes of Health), Hsu Frank (Fordham University), Jan
Freudenberg (Feinstein Medical Research Institute), Ge
Gao (Peking University, China), Chittababu Guda, (Uni-
versity of Nebraska Medical Center), Yan Guo (Vanderbilt
University), Steve Horvath (University of California, Los
Angeles), Tzu-Hung Hsiao (The University of Texas
Health Science Center at San Antonio), Kun Huang (The
Ohio State University), Weichun Huang (National
Institute of Environmental Health Sciences), Jenn-Kang
Hwang (National Chiao Tung University, Taiwan), Peilin
Jia (The University of Texas Health Science Center at
Houston), Jim W. Zheng (The University of Texas Health
Science Center at Houston), Judith Klein-Seetharaman
(University of Warwick, UK), Jun Kong (Emory Univer-
sity), Dmitry Korkin (Worcester Polytechnic Institute), K.B.
Kulasekera (University of Louisville), Fuhai Li (The Ohio
State University), Leping Li (National Institute of Environ-
mental Health Sciences), Liao Li (University of Delaware),
Honghuang Lin (Boston University), Chunyu Liu (Univer-
sity of Illinois at Chicago), Hongfang Liu (Georgetown
University), Qi Liu (Vanderbilt University), Tianming Liu
(University of Georgia), Yin Liu (The University of Texas
Health Science Center at Houston), Yunlong Liu (Indiana
University), Xinghua Lu (University of Pittsburgh), Zhiyong
Lu (NCBI, National Library of Medicine, NIH), Patricio A
Manque (Universidad Mayor, Chile), Tabrez Mohammad
(The University of Texas Health Science Center at San
Antonio), Ranadip Pal, Texas Tech University), Yonghong
Peng (University of Bradford, UK), Horacio Perez-Sanchez
(Catholic University of Murcia, Spain), Jiang Qian (Johns
Hopkins University), Thomas Rindflesch (National Insti-
tutes of Health), Marylyn Ritchie (Penn State University),
Bairong Shen (Soochow University, China), Alexander
Statnikov (New York University Langone Medical Center),
Jingchun Sun (The University of Texas Health Science
Center at Houston), Wing-Kin Sung (National Univer-
sity of Singapore, Singapore), Manabu Torii (Kaiser
Permanente Southern California), Jun Wan (John Hopkins
University), Edwin Wang (National Council of Canada/
McGill University, Canada), Guohua Wang (Harbin
Institute of Technology, China), Jing Wang (Baylor College
of Medicine), Junbai Wang (Oslo University Hospital,
Norway), Kai Wang (Columbia University), Qingguo Wang
(Memorial Sloan Kettering Cancer Center), Xiaoyan Wang
(University of Connecticut), Chaochun Wei (Shanghai Jiao
Tong University, China), Xiwei Wu (City of Hope National
Medical Center), Yonghui Wu (The University of Texas
Health Science Center at Houston), Junfeng Xia (Anhui
University, China), Lu Xie (Shanghai Center for
Bioinformation Technology, China), Hua Xu (The Univer-
sity of Texas Health Science Center at Houston), Jianhua
Xuan (Virginia Tech), Zhenqing Ye (The University of
Texas Health Science Center at San Antonio), Sungroh
Yoon (Seoul National University, Korea), Bing Zhang
(Vanderbilt University), Michelle Zhang (The University
of Texas at San Antonio), Yanqing Zhang (Georgia State
University), Min Zhao (University of the Sunshine Coast,
Australia), Huiru (Jane) Zheng (University of Ulster, UK),
Dongxiao Zhu (Wayne State University).
Publication committee
Chair: Jianhua Ruan (The University of Texas at San
Antonio), C-Chair: Yin Liu (The University of Texas
Health Science Center at Houston).
Workshop/tutorial committee
Chair: Ken Chen (MD Anderson Cancer Center), Co-
Chair: Yan Guo (Vanderbilt University).
Publicity committee
Chair: Degui Zhi (The University of Texas Health Science
Center at Houston).
Award committee
Chair: Hua Xu (The University of Texas Health Science
Center at Houston), Co-Chair: Yufei Huang (The Univer-
sity of Texas at San Antonio).
Trainee committee
Chair: Adriana Rubio (The University of Texas Health
Science Center at Houston), Co-Chair: Andrew Laitman
(Baylor College of Medicine).
Local organization committee
Chair: W. Jim Zheng, Co-Chair: Leng Han. Members:
Smita Saraykar, Rosalinda Molina, Yukiko Bryson, Marcos
Hernandez, Virginia M. Solt, Ryan Bien, all at The Univer-
sity of Texas Health Science Center at Houston.
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